Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. (Q43563104)
Jump to navigation
Jump to search
scientific article published in April 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. |
scientific article published in April 2001 |
Statements
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy (English)
Penna A
Ogg GS
Pilli M
Cavallo C
Cavalli A
Urbani S
Boehme R
Panebianco R
Fiaccadori F